Document
type: Class

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

Proceedings of the Western Pharmacology Society
type: Journal
type: Generically Dependent Continuant
type: Thing
type: Information Content Entity
type: Entity
type: Continuant
type: Collection
type: Periodical
publication venue for: Characterization of the peripheral mechanism of action involved in the potentiation of the antinociceptive effect of ketorolac by caffeine
type: Document

individual
rights: termsOfUse
date: 2026-08-28T02:05:34
publisher: vivo
type: Document
label: RDF description of Characterization of the peripheral mechanism of action involved in the potentiation of the antinociceptive effect of ketorolac by caffeine - http://orbis.uaslp.mx/vivo/individual/scopus718

Article
type: Class

Information Content Entity
type: Class

Characterization of the peripheral mechanism of action involved in the potentiation of the antinociceptive effect of ketorolac by caffeine
has publication venue: Proceedings of the Western Pharmacology Society
type: Document
estado: published
volume: 41
crisid: 719
most specific type: Article
most specific type: Document
abstract: We studied the possible peripheral mechanisms of the antinociceptive (AN) effect of ketorolac (KET) in combination with caffeine (CAP) in the pain-induced functional impairment model in the rat. CAP, by itself, did not produce any AN effect, but significantly increased the effect of KET. Since CAP did not modify KET blood concentrations, a pharmacokinetic mechanism can be excluded. We also established that CAP potentiation was not due to an antagonism of a possible pronociceptive action of adenosine, as when adenosine was given to rats treated with KET-CAF, the AN effect was further increased instead of decreasing. We have previously described that activation of the L-arginine-NO-cGMP pathway is involved in the AN effect of KET in addition to COX inhibition. Hence, we studied the participation of this pathway in CAF-induced potentiation. The NO synthesis inhibitor L-NAME was able to block CAF potentiation. Local administration of 8-Br-cGMP significantly increase the effect of the KET-CAF combination, but was ineffective by itself and also failed to increase the AN effect induced by KET alone. These results can be interpreted as follows. KET induces activation of the L-arginine-NOcGMP pathway, which contributes to its AN activity. The generated cGMP, however, is rapidly catabolized by phosphodiesterase (PD) activity. Since CAF is a nonspecific inhibitor of PD, co-administration of KET-CAF result in an accumulation of cGMP which increase the AN effect. Our results, however, do not rule out the participation of central mechanisms in addition to peripheral pathways in the potentiation of NSAID analgesia by CAF.
type: Continuant
related by: authorship 3432
type: Article
origen: scopus
related by: authorship 3433
type: Information Content Entity
related by: authorship 3430
type: Generically Dependent Continuant
type: Entity
related by: authorship 3431
date time value: article date 719
e iscopus: 2-s2.0-84865920618
page start: 269
type: Thing